COVID-19 booster update
Oct. 2022Important Notices
The FDA authorized bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines for use as a single booster dose at least two months after completing primary or booster vaccination. Anyone age 12 and older who has gotten the primary vaccination series with or without an additional booster is eligible.
Read more about COVID-19 Bivalent vaccine boosters.
Additionally, you may also visit the CDC to learn how to find a COVID-19 vaccine. Primary vaccinations and boosters for COVID-19 can be given the same day as the annual flu shot, also now available at providers and pharmacies across the Commonwealth.
For the most recent COVID-19 policy and billing updates from UPMC Health Plan, please see these resources:
- The Moderna COVID-19 Vaccine, Bivalent, is authorized for use as single booster dose in individuals 18 years old and older.
- The Pfizer-BioNTech COVID-19 Vaccine, Bivalent, is authorized for use as a single booster dose in individuals 12 years old and older.
Read more about COVID-19 Bivalent vaccine boosters.
Additionally, you may also visit the CDC to learn how to find a COVID-19 vaccine. Primary vaccinations and boosters for COVID-19 can be given the same day as the annual flu shot, also now available at providers and pharmacies across the Commonwealth.
For the most recent COVID-19 policy and billing updates from UPMC Health Plan, please see these resources:
Recent Announcements
Voluntary nationwide recall: Sucralfate (Nostrum – July)
Nostrum Laboratories, Inc. is recalling all lots of Sucralfate Tablets USP 1 gram. Sucralfate is used for the prevention and treatment of certain stomach ulcers.Jul. 2025Pharmacy Updates
Receive consultations to better support the behavioral health needs of child and adolescent patients
The Telephonic Psychiatric Consultation Service Program (TiPS) is a Pennsylvania HealthChoices program that gives primary care providers access to free, on-demand consultations with child and adolescent psychiatrists, typically within 30 minutes. It is available to providers of children and adolescents who have Pennsylvania Medicaid, Children’s Health Insurance Program, or UPMC Health Plan commercial insurance.Jul. 2025What's New
Voluntary nationwide recall: Sucralfate (Nostrum – July)
Nostrum Laboratories, Inc. is recalling all lots of Sucralfate Tablets USP 1 gram. Sucralfate is used for the prevention and treatment of certain stomach ulcers.Jul. 2025Pharmacy Updates